Status:
COMPLETED
Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
Lead Sponsor:
Providence VA Medical Center
Collaborating Sponsors:
Rhode Island Foundation
Conditions:
Diabetes
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to study whether a multidisciplinary education in Diabetes and intervention for cardiac risk reduction in a group setting to modify patient behavior and adjust medicati...
Eligibility Criteria
Inclusion
- All diabetic veterans with a Hb-A1c between 7.0- 9.0 % within the last 6 months will be eligible for the study
Exclusion
- Patients without an Hb-A1c checked within the last 6 months.
- Patients who are unable to attend the group sessions, either because of lack of transportation, psychiatric instability (suicidal, psychotic), or organic brain injury that preclude them from diabetes self-care.
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT00357955
Start Date
August 1 2004
End Date
May 1 2008
Last Update
November 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Providence VAMC
Providence, Rhode Island, United States, 02908